The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor MRNA in Muscle Cells: Implications for Myotonic Dystrophy

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2008 Jun 19

PMID 18559347

Citations 59

Authors

Libin Zhang

Jerome E Lee

Jeffrey Wilusz

Carol J Wilusz

Affiliations

Soon will be listed here.

Abstract

Type I myotonic dystrophy (DM1) is caused by a triplet repeat expansion in the 3'-untranslated region (UTR) of the dystrophia myotonia protein kinase (DMPK) gene. Pathogenesis is closely linked with production of a toxic RNA from the mutant allele, which interferes with function of several RNA-binding proteins, including CUGBP1. Here we show that expression of a mutant DMPK 3'-UTR containing 960 CUG repeats is sufficient to increase expression and stability of an mRNA encoding the potent proinflammatory cytokine, tumor necrosis factor (TNF). CUGBP1 specifically recognizes sequences within the TNF 3'-UTR that are dissimilar from its canonical UG-rich binding site. Depletion of CUGBP1 from mouse myoblasts results in increased abundance of TNF mRNA through stabilization of the transcript. Moreover, activation of the protein kinase C pathway by treatment with phorbol ester, which has been shown previously to result in CUGBP1 phosphorylation, also causes TNF mRNA stabilization. Our results suggest that the elevated serum TNF seen in DM1 patients may be derived from muscle where it is induced by expression of toxic DMPK RNA. Importantly, overexpression of this potent cytokine could contribute to the muscle wasting and insulin resistance that are characteristic of this debilitating disease.

Citing Articles

The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.

Batra R, Nelles D, Roth D, Krach F, Nutter C, Tadokoro T Nat Biomed Eng. 2020; 5(2):157-168.

PMID: 32929188 PMC: 8241012. DOI: 10.1038/s41551-020-00607-7.

Comprehensive analysis of circRNA expression profiles and circRNA-associated competing endogenous RNA networks in the development of mouse thymus.

Li W, Ma N, Yuwen T, Yu B, Zhou Y, Yao Y J Cell Mol Med. 2020; 24(11):6340-6349.

PMID: 32307889 PMC: 7294154. DOI: 10.1111/jcmm.15276.

RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21.

Liu G, Zhang Q, Xia L, Shi M, Cai J, Zhang H Cell Death Dis. 2019; 10(10):688.

PMID: 31534127 PMC: 6751195. DOI: 10.1038/s41419-019-1927-0.

Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1.

Roussel M, Morin M, Girardin M, Fortin A, Leone M, Mathieu J BMC Res Notes. 2019; 12(1):526.

PMID: 31429798 PMC: 6700834. DOI: 10.1186/s13104-019-4554-z.

HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting.

Mubaid S, Ma J, Omer A, Ashour K, Lian X, Sanchez B Proc Natl Acad Sci U S A. 2019; 116(35):17261-17270.

PMID: 31405989 PMC: 6717253. DOI: 10.1073/pnas.1905172116.

References

Jove M, Planavila A, Sanchez R, Merlos M, Laguna J, Vazquez-Carrera M . Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology. 2005; 147(1):552-61. DOI: 10.1210/en.2005-0440. View

Orengo J, Chambon P, Metzger D, Mosier D, Snipes G, Cooper T . Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A. 2008; 105(7):2646-51. PMC: 2268190. DOI: 10.1073/pnas.0708519105. View

Timchenko N, Cai Z, Welm A, Reddy S, Ashizawa T, Timchenko L . RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem. 2000; 276(11):7820-6. DOI: 10.1074/jbc.M005960200. View

Mahadevan M, Yadava R, Yu Q, Balijepalli S, Frenzel-McCardell C, Bourne T . Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet. 2006; 38(9):1066-70. PMC: 2909745. DOI: 10.1038/ng1857. View

Wang G, Kearney D, De Biasi M, Taffet G, Cooper T . Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest. 2007; 117(10):2802-11. PMC: 1964514. DOI: 10.1172/JCI32308. View

Roberts R, Timchenko N, Miller J, Reddy S, Caskey C, Swanson M . Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A. 1997; 94(24):13221-6. PMC: 24290. DOI: 10.1073/pnas.94.24.13221. View

Liu W, Feifel E, Holcomb T, Liu X, Spitaler N, Gstraunthaler G . PMA and staurosporine affect expression of the PCK gene in LLC-PK1-F+ cells. Am J Physiol. 1998; 275(3):F361-9. DOI: 10.1152/ajprenal.1998.275.3.F361. View

Chen S, Jin B, Li Y . TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol. 2006; 292(5):C1660-71. PMC: 3099536. DOI: 10.1152/ajpcell.00486.2006. View

Marquis J, Paillard L, Audic Y, Cosson B, Danos O, Le Bec C . CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J. 2006; 400(2):291-301. PMC: 1652823. DOI: 10.1042/BJ20060490. View

10.

Mukhopadhyay D, Houchen C, Kennedy S, Dieckgraefe B, Anant S . Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell. 2003; 11(1):113-26. DOI: 10.1016/s1097-2765(03)00012-1. View

11.

Johansson A, Carlstrom K, Ahren B, Cederquist K, Krylborg E, Forsberg H . Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy. J Clin Endocrinol Metab. 2000; 85(9):3169-76. DOI: 10.1210/jcem.85.9.6794. View

12.

Charlet-B N, Savkur R, Singh G, Philips A, Grice E, Cooper T . Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell. 2002; 10(1):45-53. DOI: 10.1016/s1097-2765(02)00572-5. View

13.

Amack J, Paguio A, Mahadevan M . Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum Mol Genet. 1999; 8(11):1975-84. DOI: 10.1093/hmg/8.11.1975. View

14.

Fu Y, Pizzuti A, Fenwick Jr R, King J, Rajnarayan S, Dunne P . An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992; 255(5049):1256-8. DOI: 10.1126/science.1546326. View

15.

Machuca-Tzili L, Brook D, Hilton-Jones D . Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005; 32(1):1-18. DOI: 10.1002/mus.20301. View

16.

Moraes K, Wilusz C, Wilusz J . CUG-BP binds to RNA substrates and recruits PARN deadenylase. RNA. 2006; 12(6):1084-91. PMC: 1464848. DOI: 10.1261/rna.59606. View

17.

Le Mee G, Ezzeddine N, Capri M, Ait-Ahmed O . Repeat length and RNA expression level are not primary determinants in CUG expansion toxicity in Drosophila models. PLoS One. 2008; 3(1):e1466. PMC: 2186381. DOI: 10.1371/journal.pone.0001466. View

18.

Savkur R, Philips A, Cooper T . Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet. 2001; 29(1):40-7. DOI: 10.1038/ng704. View

19.

Timchenko N, Iakova P, Cai Z, Smith J, Timchenko L . Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol. 2001; 21(20):6927-38. PMC: 99869. DOI: 10.1128/MCB.21.20.6927-6938.2001. View

20.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View